Psychosocial and demographic predictors of pediatric psychotropic medication use

S H Hong1, M D Shepherd

  • 1Division of Pharmacy Administration, University of Texas at Austin 78712-1074, USA.

Insights

Parental psychotropic medication use significantly influences children's prescription psychoactive drug use. Gender and age interact, with boys more likely to receive stimulants and girls more likely to use antidepressants at older ages.

Area of Science:

  • Pediatric pharmacology
  • Child psychology
  • Health services research

Background:

  • Children's use of prescription psychoactive medications is a growing concern.
  • Factors influencing this use, such as demographics and family environment, require investigation.

Purpose of the Study:

  • To examine the effects of age, gender, family background, and parental medication use on children's prescription psychoactive drug use.
  • To analyze these effects across different classes of psychotropic medications.

Main Methods:

  • Utilized a binary response model with logistic regression analysis.
  • Analyzed patient and prescribing data for 3144 children from prescription drug benefit plans.
  • Independent variables included family size, parenting type, parental drug use, child's age, gender, and age-gender interactions.

Main Results:

  • 3.9% of children received psychotropic drugs; parental use was a significant predictor.
  • An age-gender interaction was observed: boys more likely than girls at younger ages, girls more likely than boys at older ages.
  • Specific drug classes showed varied influences: CNS stimulants more common in boys and younger children; antidepressants less common in single-parent families; maternal drug use influenced all classes, paternal only antidepressants.

Conclusions:

  • Demographic and familial factors differentially impact children's use of various psychotropic drug classes.
  • Parental psychotropic medication use is a key factor associated with children's prescription.
  • The interplay of age and gender is crucial in understanding patterns of psychotropic medication use in children.

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...